These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15850988)
21. Effects of risedronate on osteoarthritis of the knee. Iwamoto J; Takeda T; Sato Y; Matsumoto H Yonsei Med J; 2010 Mar; 51(2):164-70. PubMed ID: 20191005 [TBL] [Abstract][Full Text] [Related]
22. Prevention of glucocorticoid-induced osteoporosis. Saag KG South Med J; 2004 Jun; 97(6):555-8. PubMed ID: 15255421 [TBL] [Abstract][Full Text] [Related]
23. Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women. Reginster JY Clin Exp Rheumatol; 2001; 19(2):121-2. PubMed ID: 11326471 [No Abstract] [Full Text] [Related]
24. Treating osteoporosis in post-menopausal women: a case approach. Keller MI Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489 [TBL] [Abstract][Full Text] [Related]
25. Conference report--scientific and clinical developments in osteoporosis. Lindsay R Medscape Womens Health; 1999 Nov; 4(6):1. PubMed ID: 10629069 [No Abstract] [Full Text] [Related]
27. Osteoporosis in men. Geier KA Orthop Nurs; 2001; 20(6):49-56. PubMed ID: 12025803 [TBL] [Abstract][Full Text] [Related]
28. [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)]. Adachi JD MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529719 [No Abstract] [Full Text] [Related]
29. Use of highly potent bisphosphonates in the treatment of osteoporosis. McClung M Curr Osteoporos Rep; 2003 Dec; 1(3):116-22. PubMed ID: 16036074 [TBL] [Abstract][Full Text] [Related]
30. [When osteoporosis first manifests itself. Without therapy the next fracture threatens]. MMW Fortschr Med; 2002 Apr; 144(14):54. PubMed ID: 12014286 [No Abstract] [Full Text] [Related]
33. [Risedronate, a new diphosphonate in osteoporosis and Paget's disease]. Bannwarth B Presse Med; 2002 Mar; 31(8):340-2. PubMed ID: 11913075 [No Abstract] [Full Text] [Related]
34. Role of alendronate and risedronate in preventing and treating osteoporosis. Peters ML; Leonard M; Licata AA Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433 [TBL] [Abstract][Full Text] [Related]
35. Bisphosphonates for osteoporosis. Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803 [TBL] [Abstract][Full Text] [Related]
36. Risedronate once a week. White NJ; Perry CM Treat Endocrinol; 2003; 2(6):415-20; discussion 421. PubMed ID: 15981945 [TBL] [Abstract][Full Text] [Related]
37. [What do we need to know--what can we do?]. Krankenpfl J; 2005; 43(7-10):217. PubMed ID: 16515289 [No Abstract] [Full Text] [Related]
38. Bisphosphonates as cancer drugs. Mundy GR Hosp Pract (1995); 1999 May; 34(5):81-4, 88-9, 93-4. PubMed ID: 10340036 [TBL] [Abstract][Full Text] [Related]
39. Prevention and treatment of glucocorticoid-induced osteoporosis in 2005. Orcel P Joint Bone Spine; 2005 Dec; 72(6):461-5. PubMed ID: 16326129 [TBL] [Abstract][Full Text] [Related]